Dec 08, 2020 – As published on Réunion la 1ère
After 5 years of work, Torskal, a start-up from Reunion Island specializing in “green nanotechnology”, is going to carry out clinical trials of a treatment it has developed for certain skin cancers. The trials will last one year and will involve around 60 people.
Testing will begin in the last quarter of next year, in Reunion Island and in mainland France. The efficiency and safety tests were conclusive. The work of the researchers is entering its operative, and therefore decisive, phase before the data is transmitted to the National Agency for the Safety of Medicines and Health Products.